Latest Stories

Latest Stories


Time for your comments

| Apr 23, 2007
You write us letters. We read them. Kai Ryssdal goes through some of your most recent comments on the student loan scandal, free trade, and the cost of flowers.

Safety as a luxury item

| Apr 23, 2007
Lexus unveiled its new flagship luxury sedan today. Its six-figure sticker price may not be for everybody, but its equipment might — someday. Brett Neely reports.

Feds on a winning streak

Scott Jagow | Apr 23, 2007
It's been a long time since federal prosecutors have lost a high-profile corporate fraud case. Newsweek's Allan Sloan says it's because government lawyers have finally learned to explain the situation in plain English.
Posted In: Wall Street

Where the concrete sidewalk ends

Nancy Farghalli | Apr 23, 2007
Concrete sidewalks have a bad habit of cracking and they're expensive to replace. So some cities are starting to replace them with a better, more sustainable alternative: recycled rubber.

Closing the persistent male-female pay gap

Nancy Marshall-Genzer | Apr 23, 2007
A new study finds the disparity between what men and women earn in the workplace begins right out of college, and only gets worse as the years go by. New legislation could help close the gap.
Posted In: Jobs

A banking behemoth is born

Stephen Beard | Apr 23, 2007
Almost. It's not a done deal yet, but Britain's Barclays is set to purchase Dutch bank ABN Amro for more than $90 billion. They've all but shut out rival bidders in what's to be the world's biggest bank buyout ever.
Posted In: Canada

Delta giving flight to voluntary carbon tax

| Apr 23, 2007
Environmentally-conscious travelers will soon have the opportunity to put their money where their mouths are. Delta is going to offer passengers an option to pay a $5 to $11 surcharge per ticket to offset carbon emissions.
Posted In: Travel

Report: Medicare is very sick

Helen Palmer | Apr 23, 2007
Today's annual report on the fiscal health of the Medicare system is expected to put forth a prognosis so bleak it will trigger the program's first-ever funding warning. And even that probably won't make a difference.
Posted In: Health

Big biopharma merger

| Apr 23, 2007
AstraZeneca, which has been struggling to get new drugs to market, is looking to get into the biological medicines game. So it's going to pay $15.6 billion for MedImmune to make it happen.
Posted In: Health

Bedlam in Bolivia

Dan Grech | Apr 23, 2007
Bolivia's government has lost control of its populace. Demonstrators from rivaling provinces have forced work stoppages and taken to the streets in an ongoing battle over who gets what share of the nation's oil and gas revenue.
Posted In: Canada